1. Home
  2. |Professionals
  3. |Emma Phillips

Emma Phillips

Associate
Associate
ZXBoaWxsaXBzQGNyb3dlbGwuY29t
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Emma Phillips is a talented negotiator who assists life sciences clients with legal agreements required to accelerate their product research and development goals.

Emma’s practice includes drafting, negotiating, and advising clients on services, consulting, and similar agreements for all stages of research and development activities and clinical trial site agreements for international, multi-center clinical studies.

Emma is an active supporter of the National Ovarian Cancer Coalition and has raised funds for the organization by running the Boston Marathon.

During law school, Emma was an Articles Editor for the Richmond Journal of Law and Technology and a member of the Technology Law Society.

Career & Education

    • Union County Superior Court, New Jersey
      Judicial intern
    • Union County Superior Court, New Jersey
      Judicial intern

    • Intern, Virginia-based firm
    • Intern, Virginia-based firm

    • Tufts University, B.A., Political Science
    • University of Richmond School of Law, J.D.
    • Tufts University, B.A., Political Science
    • University of Richmond School of Law, J.D.

    • Massachusetts
    • Massachusetts

Representative Matters

  • Supported contracting in connection with multiple companies’ multinational clinical trials, including development of custom clinical trial agreement templates, drafting and negotiating clinical trial site and related contracts, and providing project management coordination. Recent studies include:
      • A Phase 2 clinical trial of a rare disease involving approximately 40 sites across North America for a late-stage clinical biotechnology company developing treatments for metabolic, cholestatic, and fibrotic diseases;
      • A Phase 1/2a study of an immunotherapy product for treatment of recurrent bladder cancer involving approximately 10 sites throughout North America; and
      • A Phase 2 clinical trial of a cardiac genetic disorder involving approximately 11 sites across North America and Europe.
  • Drafted and negotiated agreements with a wide variety of service providers for clinical and preclinical studies of therapeutic and medical device products, including multi-million-dollar master services agreements with large, multinational contract research organizations.

Practices